Reuters: FDA clears new Johnson & Johnson HIV drug

[chris]

FDA clears new Johnson & Johnson HIV drug
      

WASHINGTON (Reuters) - Health-care products maker Johnson & Johnson  won U.S. approval to sell a new HIV drug called Intelence for patients with resistance to other therapies, U.S. officials said on Friday.
<p>You are not allowed to view links. Register or Login</p><div class="feedflare">
You are not allowed to view links. Register or Login You are not allowed to view links. Register or Login You are not allowed to view links. Register or Login
</div><img src="You are not allowed to view links. Register or Login" height="1" width="1"/>
      

You are not allowed to view links. Register or Login